Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ACTRIMS 2021 | Extracellular vesicles as nanocarriers of apo-transferrin for CNS delivery

Studies have demonstrated the ability of apo-transferrin (aTf) to induce oligodendroglial cell maturation, remyelination in animal demyelination models, and neuroprotection in humans. Therefore, studies were designed to establish a minimally invasive and controlled technique to deliver aTf to the central nervous system. Jorge Correale, MD, Raúl Carrea Institute for Neurological Research (FLENI), Buenos Aires, Argentina, discusses the use of extracellular vesicles as nanocarriers of aTf. Extracellular vesicles were isolated from mouse and human plasma, characterized and loaded with aTf through binding to Tf receptor 1. Successful loading of vesicles highlights them as potential nanovehicles to deliver aTf to the central nervous system (CNS). Further studies into their clinical application and intranasal administration are needed. This interview took place during the ACTRIMS Forum 2021.